Preparation and in vitro characterization of paclitaxel-loaded injectable microspheres
Main Article Content
Abstract
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Harpet E, Dang W, Lapidus RG, Garver RI. Enhanced efficacy of a novel
controlled release paclitaxel formulation (paclimer delivery system)
for local-regional therapy of lung cancer tumor nodules in mice. Clin
Cancer Res 1999;5:4242-8.
Johnston SR. Ovarian cancer: Review of the national institute for
clinical excellence (NICE) guidance recommendations. Cancer Invest
;22:730-42.
Watatani M, Ueda K, Daito K, Azumi T, Hirai T, Yamato M, et al. Clinical
experience of weekly paclitaxel based treatment as preoperative
chemotherapy for patients with primary breast cancer. Breast Cancer
;11:187-93.
Tarr BD, Yalkowsky SH. A new parenteral vehicle for the administration
of some poorly soluble anti-cancer drugs. J Parenter Sci Technol
;41:31-3.
Swindell CS, Krauss NE. Biologically active taxol analogues with
deleted A-ring side chain substituent and variable. J Med Chem 1991;
:1176.
Straubinger RM. Taxol®: Science and Applications. 2nd ed. New York:
CRC Publishers; 1995. p. 237-54.
Wang YM, Sato H, Horikoshi I. In vitro and in vivo evaluation of taxol
release from poly (lactic-co-glycolic acid) microspheres containing
isopropyl myristate and degradation of the microspheres. J Control
Release 1997;49:157-66.
Paradis R, Page M. New active paclitaxel amino acids derivatives with
improved water solubility. Anticancer Res 1998;18:2711-6.
Zili Z, Sfar S, Fessi H. Preparation and characterization of poly
caprolactone nanoparticles containing griseofulvin. Int J Pharm
;294:261-7.
Hiremath JG, Kusum Devi V, Kshama Devi, Domb AJ. Biodegradable
Poly (sebacic acid-co-ricinoleic-ester anhydride) tamoxifen citrate
implants: Preparation and in vitro characterization. J J Appl Polymer
Sci 2007;107:2745-54.
Jeong JC, Lee J, Cho K. Effects of crystalline microstructure on drug
release behavior of polycaprolactone microspheres. J Control Release
;92:249-58.
Elkharraz K, Faisant N, Guse C, Siepmann F, Yegin BA, Oger JM. Paclitaxel
loaded microparticles and implants for the treatment of brain cancer:
Preparation and physical characterization. Int J Pharm 2006;137:127-36.
Mu L, Feng SS. Fabrication, characterization and in vitro release of
paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres
prepared by spray drying technique with lipid/cholesterol emulsifiers.
J Control Release 2001;76:239-54.
Dubernet C. Thermo analysis of microspheres. Theor Chim Acta
;248:259-69.
Liggins RT, D’Amours S, Demetrick JS, Machan LS, Burt HM. Paclitaxel
loaded poly(l-lactic acid) microspheres for the prevention of
intraperitoneal carcinomatosis after a surgical repair and tumor cell
spill. Biomaterials 2000;19:1959-69.
Miglietta A, Cavalli R, Bocca C, Gabriel L, Gasco M. Cellular uptake and
cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin
or paclitaxel. Int J Pharm 2000;210:61-7.
Park EK, Kim SY, Lee SB, Lee YM. Folate-conjugated methoxy poly
(ethylene glycol)/poly (caprolactone) amphiphilic block copolymeric
micelles for tumor-targeted drug delivery. J Control Release
;109:158-68.